Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Pro-inflammatory markers as predictors of arterial thrombosis in aged patients with peripheral arterial disease post revascularization
Authors:ID Rodriguez Alvarez, Adriana A. (Author)
ID Cieri, Isabella F. (Author)
ID Naidu Boya, Mounika (Author)
ID Patel, Shiv (Author)
ID Agrawal, Aniket (Author)
ID Suarez Ferreira, Sasha P. (Author)
ID Alli, Christianah (Author)
ID Sharma, Shruti (Author)
ID Dua, Anahita (Author)
ID Žigon, Polona (Guest editor)
Files:.pdf PDF - Presentation file, download (355,21 KB)
MD5: 3D1163E74F748FD25F1914AFF2352DD9
 
URL URL - Source URL, visit https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1615816/full
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Abstract:Introduction: Inflammation occurs in the initial stage of arterial atherosclerosis and serves as the first step in thrombus generation, with elevated inflammatory markers predicting myocardial infarction in coronary artery disease patients. Inflammation is known to alter the course of multiple diseases and can thus, also impact recovery post-treatment and surgical outcomes. Yet, there is a paucity of data regarding the relationship between inflammatory biomarkers and arterial thrombotic potential in peripheral artery disease (PAD) patients post-revascularization. Our pilot study attempts to fill this gap by evaluating if the expression of inflammatory biomarkers in PAD patients correlates with the incidence of thrombotic events post-revascularization. Methods: Plasma samples were prospectively collected from PAD patients who underwent revascularization from 2021 to 2023 at monthly time points for 6 months from the procedure. Patients were followed for a total of 6 months post-procedure and those who experienced thrombotic events were identified. Nine patients with thrombotic events and 16 with non-thrombotic events along with 5 healthy volunteers were analyzed. Plasma samples were analyzed for the following pro-inflammatory markers: IL-1β (Interleukin-1 beta), IL-6, and TNF-α (Tumor Necrosis Factor - alpha), GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor), IFNγ (Interferon-gamma), IL-8, MCP-1 (Monocyte Chemoattractant Protein-1). The Kruskal-Wallis test was performed to compare bio-inflammatory marker levels between groups. Results: A total of 303 patients were enrolled, of which 59 had thrombotic events. There were no differences between medications or disease burden between groups. Levels of circulating IL-6 and TNF- α were significantly higher in the thrombosis cohort compared to the non-thrombosis cohort (55 vs. 38, p < 0.02) and (159 vs. 110, p < 0.02) respectively. Although there was a trend toward significance for IL-1β between the thrombotic cohort and non-thrombotic cohort, it did not reach statistical significance (18 vs. 11.5, p = NS). There was no difference observed in aspirin's ability to dampen the inflammatory response between the two groups as all patients were on aspirin between the groups evaluated. Conclusion: Pro-inflammatory markers IL-6 and TNF-α are significantly increased in patients, 1 month prior to an arterial thrombotic event, as compared to patients without thrombotic events. These biomarkers could predict impending thrombosis in patients with PAD post-revascularization.
Keywords:inflammation, interleukin-6, peripheral artery disease (PAD), thrombosis, tumor necrosis factor-alpha
Publication status:Published
Publication version:Version of Record
Year of publishing:2025
Number of pages:Str. 1-7
Numbering:Vol. 12, no. [article no.] 1615816
PID:20.500.12556/DiRROS-24667 New window
UDC:616.1/.4
ISSN on article:2296-858X
DOI:10.3389/fmed.2025.1615816 New window
COBISS.SI-ID:254748163 New window
Note:Nasl. z nasl. zaslona; Opis vira z dne 25. 10. 2025;
Publication date in DiRROS:11.12.2025
Views:40
Downloads:21
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Frontiers in medicine
Shortened title:Front. med.
Publisher:Frontiers Media S.A.
ISSN:2296-858X
COBISS.SI-ID:523095065 New window

Document is financed by a project

Funder:Other - Other funder or multiple funders
Funding programme:National Institute for Health Research
Project number:R21AG077310
Name:National Institute of Health

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:vnetje, interlevkin 6, periferna arterijska bolezen, tromboza, faktor tumorske nekroze alfa


Back